Monroe County, N.Y., funds by Health and Human Services, Department of
Listing $73,739,088.04 in stimulus funds from Health and Human Services, Department of for Monroe
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| MONROE, COUNTY OF | $2,979,898 |
ARRA Child Care and Development Block Grant ARRA Supplemental Funding for the Child Care and Development Fund (CCDF): Provide child care financial assistance to low-Income working families and fund activities to improve the quality of child care.
This spending item is part of a $96,785,640 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| ACTION FOR A BETTER COMMUNITY, INCORPORATED | $2,662,008 |
ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: Allocate funds to a network of eligible entities to support employment related services which create and sustain economic growth in keeping with the requirements of the CSBG
This spending item is part of a $86,780,940 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| ROCHESTER PRIMARY CARE NETWORK | $2,500,000 | ARRA Health Center Integrated Services Development Initiative[g1] The new Utica Community Health Center and particularly the area in which the Utica CHC is located is medically underserved and impoverished. The Utica Project will create a full-service primary care site, including medical, dental and d pharmacy services, i... Show more | Health Resources and Services Administration | 6/25/2009 |
| MONROE, COUNTY OF | $1,889,032 |
ARRA Child Care and Development Block Grant ARRA Supplemental Funding for the Child Care and Development Fund (CCDF): Provide child care financial assistance to low-Income working families and fund activities to improve the quality of child care.
This spending item is part of a $96,785,640 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| UNIVERSITY OF ROCHESTER | $1,853,655 |
Operation of a facility for the study of influenza viruses, vaccines and antimicrobials in human subjects.
This spending item is part of a $2,232,889 allocation.
See details
|
National Institutes of Health | 11/03/2009 |
| UNIVERSITY OF ROCHESTER | $1,746,185 |
Trans-NIH Recovery Act Research Support This application responds to RFA OD-08-001 Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network and proposes the renewal of U54 # NS059065 Nervous System Channelopathies: Pathogenesis and Treatment, focusing on
This spending item is part of a $2,275,663 allocation.
See details
|
National Institutes of Health | 9/20/2009 |
| UNIVERSITY OF ROCHESTER | $1,722,540 |
Trans-NIH Recovery Act Research Support Our goal is to conduct a randomized trial investigating the role of two different types of trainee and faculty mentoring in the promotion of resilience among underrepresented minorities including differently abled/disabled persons in biomedical research c
This spending item is part of a $1,986,573 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF ROCHESTER | $1,326,405 |
Trans-NIH Recovery Act Research Support Virtually all US inhabitants carry detectable levels of bisphenol-A (BPA) in their tissues. Its estrogenic properties have been recognized for decades. Although BPA had been viewed as weakly estrogenic in the past, it is now likely that exposure to low do
This spending item is part of a $1,528,307 allocation.
See details
|
National Institutes of Health | 9/27/2009 |
| UNIVERSITY OF ROCHESTER | $1,212,610 | Trans-NIH Recovery Act Research Support The project is to establish the Healthy Living Research Center at the University of Rochester. The Center will expedite research related to the translation of behavioral science to clinical and community programs and their comparative effectiveness. | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF ROCHESTER | $1,146,030 | Trans-NIH Recovery Act Research Support This study is a large-scale basic research project designed to fundamentally enhance our knowledge of how bisphenol A (BPA) affects the developing immune system and susceptibility to disease later in life. The objective of this project is to provide t | National Institutes of Health | 9/28/2009 |
| Monroe County Medical Society | $1,102,500 |
ARRA - Health Information Technology Extension Program The New York eHealth Collaborative (NYeC), in partnership with the Massachusetts eHealth Collaborative (MAeHC), is pleased to submit this response to the Regional Centers Cooperative Agreement Program Funding Opportunity Announcement to establishsh the NYeC... Show more
This spending item is part of a $27,589,318 allocation.
See details
|
Health and Human Services, Department of | 2/08/2010 |
| UNIVERSITY OF ROCHESTER | $1,076,443 |
Trans-NIH Recovery Act Research Support This project would entail expanding the current 12-color panels we have in two ways: 1) to create new 12-color panels that in addition to 6-8 anchor markers that recognize the main populations also incorporate markers of activation, inhibition/exhaustion
This spending item is part of a $1,290,000 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF ROCHESTER | $1,000,000 | Trans-NIH Recovery Act Research Support This RC1 grant application is responsive to Challenge Area 04-Clinical Research and specifically to the NHLBI Challenge Topic 04-HL-103: Assess the role of leukocyte interaction with platelets, erythrocytes, and endothelium in the pathogenesis of heart, l | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF ROCHESTER | $999,997 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (04) Clinical Research, and specific Challenge Topic, 04-ES-102: Investigating gene x environment interaction using controlled human exposures. Increases in ambient particulate matter (PM) are associated wit | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $986,900 | Trans-NIH Recovery Act Research Support In accord with the goals and strategic vision of the Center, the Career Development Program (CDP) has three major goals. These include: 1) successful mentoring and career development of junior faculty; 2) recruitment and mentoring of investigators new | National Institutes of Health | 9/27/2010 |
| ROCHESTER PRIMARY CARE NETWORK | $975,256 | ARRA Health Center Integrated Services Development Initiative[g1] To meet the increased demand for services and create employment opportunities in underserved areas, RPCN will expand hours of operation, expand services and add new providers. New outreach and marketing will also be conducted, especialally to the refugee po... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF ROCHESTER | $936,627 | Trans-NIH Recovery Act Research Support This application addresses the broad Challenge Area (06) Enabling Technologies, and specific Challenge Topic, 06-OD(OBSSR)-101*: Using new technologies to improve or measure adherence. We propose the development and testing of a novel technology to improv | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF ROCHESTER | $921,000 | Trans-NIH Recovery Act Research Support The central hypothesis of this application is that impairment of myelination, irrespective of the mechanisms, can be diagnosed and characterized by utilizing auditory brain stem recordings and analysis as a sensitive and non-invasive diagnostic tool. We | National Institutes of Health | 1/07/2010 |
| UNIVERSITY OF ROCHESTER | $916,778 | Trans-NIH Recovery Act Research Support Semen contains cationic amyloid fibrils derived from proteolytic cleavage fragments of prostatic acid phosphatase (PAP) that efficiently capture HIV-1 particles. These fibrils have been termed semen-derived enhancer of viral infection (SEVI) and enhance H | National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF ROCHESTER | $860,397 |
Trans-NIH Recovery Act Research Support Engineered nanomaterials (ENM) have the potential to revolutionize every-day life due to unique properties that have led to advances in electronics, materials science, and drug delivery. Many types of ENM are produced by the metric ton per year and, thus
This spending item is part of a $1,360,282 allocation.
See details
|
National Institutes of Health | 9/26/2009 |
| OAK ORCHARD COMMUNITY HEALTH CENTER, INC. | $827,325 | ARRA Health Center Integrated Services Development Initiative[g1] This grant under the American Recovery and Reinvestment Act is entitled Capital Improvement Program. These funds enable us to undertake renovations at three of our sites:Brockport,Albion and Lyndonville. Funds are also being used to pupurchase much needed e... Show more | Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF ROCHESTER | $824,680 | Trans-NIH Recovery Act Research Support We propose to acquire an 18-color, 5-laser BD Biosciences FACSAria-II cell sorter, with bio- containment hood and novel CellEvator acoustic wave powered sample mixer technology. This instrument will expand the availability of researchers to access cell so | National Institutes of Health | 1/07/2010 |
| UNIVERSITY OF ROCHESTER | $822,518 |
Trans-NIH Recovery Act Research Support The proposed study will focus on an essential but neglected area of HIV prevention research: sexual behavior and determinants of HIV risk among adult minority men who have sex with women (MSW) in urban settings. Heterosexual transmission of HIV has steadi
This spending item is part of a $999,743 allocation.
See details
|
National Institutes of Health | 8/04/2009 |
| CARESTREAM HEALTH INC | $802,532 | NIH currently uses Carestream PACS 10.1 Clustered Workflow Mgr (WFM) Servers (Sun 880 platforms) with attached EMC CX400 RAID. All image data is located on a CX400 RAID with DLT tape backup & storage at an offsite location. NIH also has Carestream PACS v1 | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $801,398 | Trans-NIH Recovery Act Research Support The purpose of the American Recovery and Reinvestment Act of 2009 is to create jobs, and for NIH awards to fund science in pursuit of improving the length and the quality of the lives of U.S. citizens, while at the same time stimulating the economy. This | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $767,292 | Trans-NIH Recovery Act Research Support This application is a revised competitive renewal of our grant that is focused on understanding the mechanisms by which mutant huntingtin impairs mitochondrial function. In March 2007 I relocated to the University of Rochester specifically to join the Mit | National Institutes of Health | 8/05/2009 |
| UNIVERSITY OF ROCHESTER | $767,221 | Trans-NIH Recovery Act Research Support This proposal presents the rationale for a request for initial funds to hire a new tenure-track faculty member in the RNA Center for Biology at the University of Rochester Medical Center. The faculty member will join a highly integrated and interactive gr | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $760,624 | Trans-NIH Recovery Act Research Support Streptococcus pneumoniae (S.p.), an important human pathogen causing pneumonia, is a major cause of morbidity and mortality worldwide. Its early mortality rate still remains the highest when compared to the pre-antibiotic era. Pneumolysin (PLY), a key cyt | National Institutes of Health | 9/11/2009 |
| UNIVERSITY OF ROCHESTER | $755,599 | Trans-NIH Recovery Act Research Support The developing mouse tooth has long been used as a powerful model system for studying the molecular mechanisms regulating organ development and the pathogenic mechanisms of tooth developmental anomalies in humans. Tissue recombination studies and extensiv | National Institutes of Health | 7/20/2009 |
| ACTION FOR A BETTER COMMUNITY, INCORPORATED | $753,695 |
ARRA - Head Start This award provides for ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act for the Head Start and Early Head Start programs. Head Start/Early Head Start promote t
This spending item is part of a $812,521 allocation.
See details
|
Administration for Children and Families | 7/02/2009 |
| UNIVERSITY OF ROCHESTER | $744,313 | Trans-NIH Recovery Act Research Support The main Rochester Human Immunology Center grant supports development and deployment of expertise in sophisticated immunological assays, but the original application did not support biochemical purification and conjugation of proteins. As production of a | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF ROCHESTER | $695,098 | Trans-NIH Recovery Act Research Support This application addresses broad challenge area (10) Information Technology for Processing Health Care Data for Research' and specific challenge topic 10-CA-102 Predictive Mathematical Models of Normal and Cancer Processes. This proposal will develop mat | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $690,750 | Trans-NIH Recovery Act Research Support Congenital diaphragmatic defects are common birth defects with high morbidity and mortality secondary to associated pulmonary hypoplasia. Despite the significant impact that these defects have, the molecular mechanisms underlying their development are not | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $667,606 | Trans-NIH Recovery Act Research Support Neurological symptoms with methamphetamine (METH) toxicity of the nigrostriatal system, both in rodent models and in drug abusers, are associated with neuroinflammation, a fundamental reaction to brain injury characterized by activated microglia and astro | National Institutes of Health | 7/16/2009 |
| IT PRACTICE CONSULTING COR | $659,375 |
ARRA - Health Information Technology Extension Program The New York eHealth Collaborative (NYeC), in partnership with the Massachusetts eHealth Collaborative (MAeHC), is pleased to submit this response to the Regional Centers Cooperative Agreement Program Funding Opportunity Announcement to establishsh the NYeC... Show more
This spending item is part of a $27,589,318 allocation.
See details
|
Health and Human Services, Department of | 2/08/2010 |
| UNIVERSITY OF ROCHESTER | $648,765 |
Trans-NIH Recovery Act Research Support The long range goal of this translational-engineering research project is to improve the vision of people who have abnormal corneal conditions such as keratoconus. In the previous grant period, we developed the ability to measure wavefront error in these
This spending item is part of a $764,231 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $647,680 | Trans-NIH Recovery Act Research Support This proposal seeks to support a research program in the area of tissue engineering in the musculoskeletal sciences. It is aimed at enriching the infrastructure of a translational research partnership at the University of Rochester. The partnership is bet | National Institutes of Health | 9/23/2009 |
| UNIVERSITY OF ROCHESTER | $637,025 | Trans-NIH Recovery Act Research Support Epigenetic dysregulation and genetic mutations both contribute to cancer development. While genetic mutations such as gain-of-function mutations in oncogenes and loss-of-function mutations in tumor suppressors have been extensively studied, the mechanisms | National Institutes of Health | 5/05/2009 |
| UNIVERSITY OF ROCHESTER | $626,647 | ARRA - Preventive Medicine Residency Program The purpose of this project is to provide financial support for state-of-the-art training of preventive medicine residents, and to improve our existing Preventive Medicine training program, by addressing five specific needs/objectives that have been identt... Show more | Health Resources and Services Administration | 7/02/2010 |
| UNIVERSITY OF ROCHESTER | $600,601 | Trans-NIH Recovery Act Research Support B cell signatures in SLE - Justification: Provide the best and most extensive clinical and immunological characterization of any Lupus cohort and will extend the ACE studies. Longitudinal 2-year follow-up of 250 Lupus patients (3x/year for a total of 1,5 | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF ROCHESTER | $598,483 | Trans-NIH Recovery Act Research Support The project proposes to establish, in collaboration with the Morehouse School of Medicine (MSM) the RICE (Research in Comparative Effectiveness) Network, a practice-based research network (PBRN) specializing in comparative effectiveness research (CER). Th | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF ROCHESTER | $586,183 |
Trans-NIH Recovery Act Research Support This grant application is a companion to the application submitted by Dr. Mark Kupersmith for the Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC). This application describes a Data Coordination and Biostatistics Center (DCBC), a Vis
This spending item is part of a $700,000 allocation.
See details
|
National Institutes of Health | 8/19/2009 |
| UNIVERSITY OF ROCHESTER | $566,324 |
Trans-NIH Recovery Act Research Support Our goal is to sketch out the broad principles by which these ncRNAs acquire activity from structure, which will provide a foundation to develop new therapeutic agents and the next generation of antibiotics. Non-protein-coding (nc)RNAs are undergoing
This spending item is part of a $673,524 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
| ANTHONY L JORDAN HEALTH CORP | $545,618 |
ARRA Health Center Integrated Services Development Initiative[g1] Capital Improvement Program
This spending item is part of a $1,027,840 allocation.
See details
|
Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF ROCHESTER | $544,275 |
Trans-NIH Recovery Act Research Support Cardiovascular disease is the number one killer of Americans, claiming over 500,000 lives annually. These deaths occur when the fibrous cap of an atherosclerotic plaque ruptures in the later stages of the disease. Current screening tests for the diagnosis
This spending item is part of a $803,526 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $537,562 | Trans-NIH Recovery Act Research Support This Science Education Partnership Award (SEPA) supplement grant will support broader dissemination and adoption of our SEPA-funded curriculum modules.-? It will also provide opportunities for increasing the involvement of scientists in bringing informati | National Institutes of Health | 8/01/2009 |
| PATHSTONE CORPORATION | $534,066 |
ARRA - Community Services Block Grant ARRA Supplemental Funding for the Community Services Block Grant (CSBG) Program: Allocate funds to a network of eligible entities to support employment related services which create and sustain economic growth in keeping with the requirements of the CSBG
This spending item is part of a $86,780,940 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
| UNIVERSITY OF ROCHESTER | $525,577 | Trans-NIH Recovery Act Research Support Infections caused by Staphylococcus aureus span a wide clinical spectrum, ranging from asymptomatic nasal carriage to endocarditis, bone and joint infections and lethal shock. Increasing rates of S. aureus infection and the emergence of community-acquired | National Institutes of Health | 8/19/2010 |
| UNIVERSITY OF ROCHESTER | $518,353 | Trans-NIH Recovery Act Research Support The University of Rochester hosts a vibrant, interdisciplinary team of scientists working on projects at the intersection of metabolic regulation and aging. We have identified several areas of competence that would strategically strengthen this group. The | National Institutes of Health | 9/21/2009 |
| BELL BCI COMPANY, LLC | $514,000 |
Construction of the NIH Porter Neuroscience Research Center Phase II. The project is approximately 300,000 GSF.
This spending item is part of a $157,030,324 allocation.
See details
|
National Institutes of Health | 5/13/2010 |
| UNIVERSITY OF ROCHESTER | $499,800 | Trans-NIH Recovery Act Research Support This is a proposal to establish high throughput DNA sequencing technology at the University of Rochester. The University has a rich portfolio of NIH-funded research that would benefit from access to high throughput DNA sequencing. Diverse projects, rangin | National Institutes of Health | 5/06/2010 |
| UNIVERSITY OF ROCHESTER | $484,594 | Trans-NIH Recovery Act Research Support The goals of this administrative supplement are (i) to accelerate the progress of the Parent Grant (AI-068056), (ii) to expand our studies of influenza to the new pandemic H1N1 strain of flu and (iii) to stimulate the economy of upstate NY. These goal | National Institutes of Health | 9/21/2009 |
| WESTSIDE HEALTH SERVICES INC | $482,222 |
ARRA Health Center Integrated Services Development Initiative[g1] Capital Improvement Program
This spending item is part of a $1,027,840 allocation.
See details
|
Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF ROCHESTER | $477,916 | Trans-NIH Recovery Act Research Support The University of Rochester Medical Center has targeted X-ray crystallography as an area for strategic development due to its potential for high impact on existing NIH-funded research programs and Centers. A limiting factor in this plan is that our curren | National Institutes of Health | 1/28/2010 |
| UNIVERSITY OF ROCHESTER | $442,868 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (05): Comparative Effectiveness Research and Specific Challenge topic 05-LM-104* Value of 'Virtual Reality' Interaction in Improving Compliance with Diabetic Regimen. Diabetes has become a serious public hea
This spending item is part of a $959,658 allocation.
See details
|
National Institutes of Health | 8/24/2010 |
| UNIVERSITY OF ROCHESTER | $434,983 | Trans-NIH Recovery Act Research Support This current application addresses Regenerative Medicine (11) as the broad challenge area. Specifically, this application seeks further understanding of molecular pathways that control expansion and differentiation of periosteal mesenchymal stem cells (MS | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF ROCHESTER | $433,731 | Trans-NIH Recovery Act Research Support Our long term goal is to study the mechanism of neurodegeneration induced by environmental neurotoxicants. This proposal is submitted to investigate gene-environment interactions in the pathogenesis of Parkinson's disease mediated through the mitochondria | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $428,203 | Trans-NIH Recovery Act Research Support Confocal microscopy has become a fundamental tool in biomedical research in recent years, thanks to advances in imaging technology that allow for obtaining images of extremely high resolution and quality from various types of tissues and cells. This pro | National Institutes of Health | 6/24/2010 |
| UNIVERSITY OF ROCHESTER | $423,396 | Trans-NIH Recovery Act Research Support Candida albicans is an important opportunistic fungal pathogen that causes both mucosal and invasive disease in immunocompromised patients. Nearly all HIV/AIDS patients will develop oropharyngeal (OPC) or esophageal candidiasis during their lifetime. Beca | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $422,313 | Trans-NIH Recovery Act Research Support Neisseria gonorrhoeae is the causative agent of gonorrhea, one of the most prevalent infectious diseases in this country. In addition to local infection, manifested as urethritis or cervicitis, the gonococcus can cause serious complications, including pel | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF ROCHESTER | $422,250 | Trans-NIH Recovery Act Research Support Influenza is a globally important respiratory pathogen that causes nearly annual epidemics and occasional pandemics. Recent spread of highly pathogenic avian influenza H5N1 viruses is a new threat that may lead to a deadly influenza pandemic. Influenza an | National Institutes of Health | 5/04/2009 |
| UNIVERSITY OF ROCHESTER | $422,239 | Trans-NIH Recovery Act Research Support The resurgence of tuberculosis and the spread of antibiotic resistant strains of the causative agent, Mycobacterium tuberculosis, present a significant public health challenge. Tuberculosis kills nearly 2 million people each year and estimates put the wor | National Institutes of Health | 5/29/2009 |
| UNIVERSITY OF ROCHESTER | $422,125 | Trans-NIH Recovery Act Research Support Epidemic typhus, also known as Gaol fever, Jail fever, or Famine fever, is caused by the Gram-negative bacterium Rickettsia prowazekii. This louse-borne disease has been responsible for devastating widespread epidemics throughout history, especially durin | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF ROCHESTER | $421,578 | Trans-NIH Recovery Act Research Support In collaboration with members of the national Biostatistics, Epidemiology, Research Design (BERD) Online Resources and Education task force, we have subsequently made significant progress addressing the defined specific aims and fostering collaboration wi | National Institutes of Health | 9/09/2010 |
| UNIVERSITY OF ROCHESTER | $414,803 | Trans-NIH Recovery Act Research Support The focus of the parent proposal (Understanding the Generation of HIV Broadly Neutralizing Antibodies) is to define the critical aspects of the cellular processes leading to the generation, or lack thereof, of BNA. This is vital as the success of any vacc | National Institutes of Health | 7/26/2010 |
| UNIVERSITY OF ROCHESTER | $384,595 | Trans-NIH Recovery Act Research Support Proper B cell tolerance ensures effective censoring of autoreactive B cells thereby avoiding their participation in effector pathogenic response and preventing autoimmune diseases. The breakdown of B cell tolerance is at the core Systemic Lupus Erythemat | National Institutes of Health | 7/23/2009 |
| UNIVERSITY OF ROCHESTER | $375,000 | Trans-NIH Recovery Act Research Support The project comprises 3 enhancements to an existing Center of Research Translation grant, entitled Translating molecular signal pathways to orthopaedic trauma care. The first provides salary support for personnel and animal/supply support to conduct expe | National Institutes of Health | 9/22/2009 |
| UNIVERSITY OF ROCHESTER | $373,220 |
ARRA - Preventing Healthcare-Associated Infections This proposalseekstoprovidecontinuedsupportfor the New YorkState EmergingInfectionsProgram (NYSEIP). The NewYork State Departmentof Health(NYSDOH), in conjunctionwiththe Universityof Rochester(U of R) andthe NewYork City Departmentof Healthand MentalalHygie... Show more
This spending item is part of a $392,863 allocation.
See details
|
Centers for Disease Control and Prevention | 8/31/2009 |
| UNIVERSITY OF ROCHESTER | $370,097 | Trans-NIH Recovery Act Research Support This is an award to purchase an IVIS Spectrum Multimodal (multispectral bioluminescence and fluorescence) Imaging instrument. The shared instrument will compliment and boost the extensive imaging resources available to University of Rochester Medical Cent | National Institutes of Health | 6/03/2010 |
| UNIVERSITY OF ROCHESTER | $364,762 | Trans-NIH Recovery Act Research Support This shared instrumentation proposal seeks funds to purchase a state-of-the-art BIAcore T100 instrument for the University of Rochester. No instrument comparable to the T100 is available in the Rochester area. An in- house Reichert SR7000 instrument has l | National Institutes of Health | 1/07/2010 |
| UNIVERSITY OF ROCHESTER | $346,143 | Trans-NIH Recovery Act Research Support During aging there is a progressive decline in the function of most organs and tissues. Our data show that the ECM protein, fibronectin (FN), regulates the deposition and turnover of other ECM molecules including collagen I, collagen III, thrombospondin | National Institutes of Health | 5/20/2009 |
| UNIVERSITY OF ROCHESTER | $340,145 | Trans-NIH Recovery Act Research Support Microscopic examination of benign and malignant tissues from humans and from animals is an essential component of many NIH-funded research projects. The whole slide imager will be used to make digital pictures of tissues that are now preserved on glass sl | National Institutes of Health | 5/13/2010 |
| UNITY HOSPITAL OF ROCHESTER, THE | $331,655 | ARRA Health Center Integrated Services Development Initiative[g1] The ARRA CIP funds awarded to the Health Reach- HCH was used to renovate existing space within our health system to create a dedicated homeless clinic which would increase access to primary health care for the homeless population we seserve. The end result... Show more | Health Resources and Services Administration | 6/25/2009 |
| UNIVERSITY OF ROCHESTER | $310,696 |
Trans-NIH Recovery Act Research Support Project objective: This project will perform annual cognitive evaluations on subjects previously enrolled in the Alzheimer's Disease Anti-Inflammatory Protection Trial (ADAPT). The purpose of these evaluations is to extend observations on the ADAPT outc
This spending item is part of a $5,985,586 allocation.
See details
|
National Institutes of Health | 8/12/2009 |
| UNIVERSITY OF ROCHESTER | $309,807 | Trans-NIH Recovery Act Research Support This award is an administrative supplement to enhance the comparative effectiveness research activities for the oR34 study entitled Forensic Assertive Community Treatment: An Emerging Model of Care.-? This administrative supplement award will accelerate s | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF ROCHESTER | $308,000 | Trans-NIH Recovery Act Research Support Otitis media (OM) is the most common childhood bacterial infection and also the leading cause of conductive hearing loss in children. Inflammation in the middle ear caused by microorganisms is a hallmark of OM. Nontypeable Haemophilus influenzae (NTHi) is | National Institutes of Health | 5/05/2009 |
| UNIVERSITY OF ROCHESTER | $301,387 | Trans-NIH Recovery Act Research Support Funding of this supplement will, among other things, ensure the development and retention of a junior faculty member with unique expertise in neonatal lung injury who otherwise would have to pursue other research. The central theme of our Center is the c | National Institutes of Health | 9/21/2009 |
| UNIVERSITY OF ROCHESTER | $299,036 | Trans-NIH Recovery Act Research Support This project will expand the content on CTSpedia to include additional encyclopedic articles, statistical tools for analysis, and editable and freely shared articles of course materials. With the funding from this project, we also propose to continue to | National Institutes of Health | 9/17/2009 |
| UNIVERSITY OF ROCHESTER | $297,242 | ARRA ? Equipment to Enhance Training for Health Professionals The ARRA Equipment to Enhance Training for Health Professionals (EETHP) grant will enahnce my current HRSA funded training project The Greater Rochester Nursing Home Quality Consortium. The purpose of the Consortium is to train interdisciciplinary teams in... Show more | Health Resources and Services Administration | 9/02/2010 |
| ROCHESTER GENERAL HOSPITAL | $293,717 |
Trans-NIH Recovery Act Research Support NTHi Immunity in Young Children (Accelerating the Science supplement): Within the scope of the parent study of acute otitis media (AOM), this supplemental project seeks support to accelerate the tempo of scientific research, increase diversity recruitmen
This spending item is part of a $309,776 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $292,233 | Trans-NIH Recovery Act Research Support Brain function depends on precisely organized neural networks. A central problem in contemporary neuroscience has been to determine how the specific organization of synaptic inputs is established in the brain during development. Uncovering the identity of | National Institutes of Health | 6/11/2009 |
| UNIVERSITY OF ROCHESTER | $291,787 |
ARRA - Immunization This proposalseekstoprovidecontinuedsupportfor the New YorkState EmergingInfectionsProgram (NYSEIP). The NewYork State Departmentof Health(NYSDOH), in conjunctionwiththe Universityof Rochester(U of R) andthe NewYork City Departmentof Healthand MentalHygie
This spending item is part of a $731,550 allocation.
See details
|
Centers for Disease Control and Prevention | 9/01/2009 |
| ANTHONY L JORDAN HEALTH CORP | $285,815 | ARRA Health Center Integrated Services Development Initiative[g1] IDS Grant is for recruitment and retention of employees. The need at the facility is to expand and retain the clinical team in order to meet the need of the patients at that facility(Westside) and Anthony Jordan is seeing a rise in dedemand for services fr... Show more | Health Resources and Services Administration | 3/27/2009 |
| ANTHONY L JORDAN HEALTH CORP | $285,815 | ARRA Health Center Integrated Services Development Initiative[g1] IDS Grant is for recruitment and retention of employees | Health Resources and Services Administration | 6/29/2009 |
| UNIVERSITY OF ROCHESTER | $281,831 | Trans-NIH Recovery Act Research Support This proposal is testing the hypothesis that adverse developmental outcomes in children are associated with exposure to methyl mercury (MeHg) from consumption of a diet high in fish. Since 1989, the Seychelles Child Development Study (SCDS) has been follo | National Institutes of Health | 9/06/2009 |
| UNIVERSITY OF ROCHESTER | $276,150 |
Trans-NIH Recovery Act Research Support Many important diseases, including malaria, hepatitis and AIDS, could be eliminated by successful vaccines. However, such vaccines are elusive. This project aims to develop a new approach to making vaccines more effective. Our research has revealed an une
This spending item is part of a $434,268 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
| UNIVERSITY OF ROCHESTER | $274,894 | Trans-NIH Recovery Act Research Support Cognitive skills and their underlying brain organization are not fixed but can be shaped by the experience of the individual. The extent of such experience-dependent plasticity provides valuable information about the ability of the nervous system to reorg | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $270,220 | Trans-NIH Recovery Act Research Support With the scientific progression, we found that the radiation-induced alteration of electrolyte transportation could be reversed towards normal as evidenced by the Ussing Chamber assay. The supplemental money allowed us to facilitate this part of study by | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF ROCHESTER | $261,365 | Trans-NIH Recovery Act Research Support This supplemental request is focused on providing financial support for an additional post-doctoral fellow to accelerate the rate of scientific progress of the funded parent grant research. This 2 year supplement is requesting salary and research supply s | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF ROCHESTER | $260,142 |
Trans-NIH Recovery Act Research Support To support research and other projects that will support fundamental biomedical discovery and translation of that knowledge into effective prevention strategies and new treatments while also providing economic stimulus to the nation.
This spending item is part of a $1,554,684 allocation.
See details
|
National Institutes of Health | 5/07/2009 |
| UNIVERSITY OF ROCHESTER | $259,562 | Trans-NIH Recovery Act Research Support The Administrative Supplement grant will help to accelerate our scientific discovery by ensuring sufficient personnel effort and purchasing urgently needed equipment, thereby accelerating the translation of these basic discoveries into the clinical applic | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $250,108 | Trans-NIH Recovery Act Research Support The purpose of the administrative supplement is to accelerate and deepen our studies on the mechanisms by which silencers establish transcriptionally silent chromatin, and protosilencers facilitate silencer function in the yeast Saccharomyces cerevisiae. | National Institutes of Health | 7/17/2009 |
| OAK ORCHARD COMMUNITY HEALTH CENTER, INC. | $249,655 | ARRA Health Center Integrated Services Development Initiative[g1] This grant under the American Recovery and Reinvestment Act is entitled Increased Demand for Services.These funds are being utilized to increase services at existing sites and for spikes in demand to serve uninsured populations.With t these funds we are ab... Show more | Health Resources and Services Administration | 3/27/2009 |
| UNIVERSITY OF ROCHESTER | $238,014 | Trans-NIH Recovery Act Research Support This administrative supplement to the parent R01 aims to accelerate our project investigating the functional role of Mena (the mammalian homologue of drosophila enabled) in the heart. | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $237,695 | Trans-NIH Recovery Act Research Support In this Administrative Supplement, we will examine the potential role of PECAM1 in fluid shear stress-mediated VEGFR2/Gab1/eNOS signal pathway, which is involved in flow atheroprective effects. | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $235,048 | Trans-NIH Recovery Act Research Support A Ph.D. Candidate will work on the project to minimize delays in the project and will include, basic lab supplies, experiment reagents, and a data analysis workstation. | National Institutes of Health | 8/01/2009 |
| UNIVERSITY OF ROCHESTER | $221,021 |
To design and test a method of intervention that has the capacity to promote engagement and adherence to treatment, foster recovery and reduce or prevent disability in patients experiencing a first episode of schizophrenia and related psychotic disorders.
This spending item is part of a $10,496,230 allocation.
See details
|
National Institutes of Health | 7/13/2009 |
| UNIVERSITY OF ROCHESTER | $213,616 | Trans-NIH Recovery Act Research Support The administrative supplement funding will be used to develop a novel near infrared imaging method to quantify lymphatic draining function in the joint tissues of murine models of arthritis and to examine if improved lymphatic flow could reduce the joint | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF ROCHESTER | $206,888 | Trans-NIH Recovery Act Research Support The administrative supplement will be used to hire a postdoctoral associate, who will work on Aim #3 of the original award. The postdoctoral researcher is essential to the project, as the graduate students working on the grant are in the first half of th | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF ROCHESTER | $206,671 |
Trans-NIH Recovery Act Research Support Intravascular ultrasound (IVUS) imaging is a technology that enables realtime tomographic assessment of the arterial wall and it is increasingly employed to assist in selecting and evaluating therapeutic interventions. While new catheter designs have been
This spending item is part of a $965,463 allocation.
See details
|
National Institutes of Health | 8/28/2009 |
| UNIVERSITY OF ROCHESTER | $205,288 | Trans-NIH Recovery Act Research Support The purpose of this administrative supplement is to support a new collaboration (subcontract with Dr. Michael Lovett at Washington University) to use the next-generation sequencing technologies to sequence the entire genomic region containing the Twirler | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF ROCHESTER | $199,861 | Trans-NIH Recovery Act Research Support This grant supplement will support studies of a new therapeutic for pulmonary fibrosis (scarring). Studies will examine the role of small molecule ligands for the peroxisome proliferator activated receptor gamma (PPARg) in preventing and inhibititing prog | National Institutes of Health | 7/16/2009 |
| UNIVERSITY OF ROCHESTER | $193,225 |
Trans-NIH Recovery Act Research Support Obstruction voiding disorder (OVD) and high-grade prostatic intraepithelial neoplasia (HGPIN) are common diseases of aging men. HGPIN is a precancerous lesion that usually leads to aggressive therapy upon detection. There has long been speculation that th
This spending item is part of a $900,000 allocation.
See details
|
National Institutes of Health | 9/27/2009 |
| UNIVERSITY OF ROCHESTER | $192,673 | Trans-NIH Recovery Act Research Support Funding from this administrative supplement will be used to hire a technician. This will alleviate the administrative/lab management responsibilities of individuals who are working on the question proposed in the supplement: How is the process of nonsense | National Institutes of Health | 9/09/2009 |
| UNIVERSITY OF ROCHESTER | $188,471 | Trans-NIH Recovery Act Research Support The Aim of this proposal is to implement internet enabled tissue banking and patient annotation software for the collection of esophageal cancer specimens and data at the University of Rochester and the University of Pittsburgh. Our goal is to create a co | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF ROCHESTER | $187,480 | Trans-NIH Recovery Act Research Support The two major goals in the parent grant for which this application requests an administrative supplement were: (1) test the hypothesis that myofibroblasts, through localized contraction of the corneal stroma, are responsible for the significant increase i | National Institutes of Health | 1/29/2010 |
| UNIVERSITY OF ROCHESTER | $183,795 | Trans-NIH Recovery Act Research Support This supplement grant will support broader dissemination and adoption of our SEPA-funded curriculum modules. It will also provide opportunities for increasing the involvement of scientists in bringing information on biomedical science and research to hig | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $180,061 | Trans-NIH Recovery Act Research Support The supplement allows us to perform experiments related to the first specific aim of the grant but which were not proposed originally. Our novel findings related to the linearity of central vestibular neuronal responses will be further developed using ne | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $177,592 | Trans-NIH Recovery Act Research Support This supplement allows us to access new imaging technology to characterize the dendritic cell intra-cellular altered signaling and receptor co localization which contribute to post injury pathology. -?A new post doctorial fellow position, training in this | National Institutes of Health | 9/08/2009 |
| CARESTREAM HEALTH, INC. | $168,810 | Task Order issued for equipment that digitally captures, transmits, and prints medical diagnostics images to improve patient care and reduce waiting time for diagnosis. Vendor will provide digital Cassettes Readers (CR) to capture diagnostic images at the | Indian Health Service | 6/30/2010 |
| UNIVERSITY OF ROCHESTER | $168,588 | Trans-NIH Recovery Act Research Support One major group of general aims of our research is to identify N-terminal acetyltransferases (NATs), their subunit composition, their substrates, their functions and their interactions. In general, much of our research is hampered by the lack of properly | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $163,094 | Trans-NIH Recovery Act Research Support The supplement will support the additional of a new professional staff person, a computer programmer, to our project. This new position will focus on the development of advanced physiological data analysis software, specifically to handle the large quanti | National Institutes of Health | 8/01/2009 |
| Rochester Clinical Research, Inc | $154,400 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $153,584 | Trans-NIH Recovery Act Research Support Ataxia Telangiectasia (AT) is a genetic disorder that surprisingly manifests itself only in certain tissues. This tissue preference is especially relevant to the AT-affected CNS, in which degeneration of the cerebellar cortex and subsequently many of its | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF ROCHESTER | $153,521 | Trans-NIH Recovery Act Research Support The overall goal of this application is to explore the involvement of non-classical MHC class Ib (class Ib) molecules in thymocyte differentiation during early development by a comparative approach in the Xenopus. Increasing evidence suggests that in the | National Institutes of Health | 8/11/2009 |
| UNIVERSITY OF ROCHESTER | $151,884 | Trans-NIH Recovery Act Research Support The purpose of this Administrative Supplement is to accelerate the pace of scientific discovery on the aims of the parent grant, which examines the specificity and familiality of chemosensory function and eating behavior in autism. Through the suppleme | National Institutes of Health | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $151,463 | Trans-NIH Recovery Act Research Support This award is for equipment only. The University of Rochester Medical Center (URMC) is sponsoring the construction of a new enhanced Animal Biosafety Level 3 (eABSL3) facility in shell space of the URMC MRBX basement. The facility is being designed to sa | National Institutes of Health | 8/14/2009 |
| HIGHLAND HOSPITAL OF ROCHESTER | $147,453 |
Trans-NIH Recovery Act Research Support Our parent grant, Patient Navigation Research Program (PNRP) is evaluating the impact of patient navigation on breast cancer (BC), and colorectal cancer (CC) related quality of care and is evaluating the impact of patient navigation on disparities in canc
This spending item is part of a $213,978 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF ROCHESTER | $145,783 | Trans-NIH Recovery Act Research Support This small project will complete testing and development of an agent-based computational model of multi-cell migration in the classic scratch wound assay. The model attempts to mimic experiments on a simple immortal cell type (3T3-L1 fibroblasts) without | National Institutes of Health | 5/08/2009 |
| UNIVERSITY OF ROCHESTER | $144,284 | Trans-NIH Recovery Act Research Support The long term goal of our research program is to understand the functional role(s) of the vestibular efferent system. The current objective is to close the gap between the synaptic actions of vestibular efferent stimulation and the functional, physiolog | National Institutes of Health | 8/14/2009 |
| UNIVERSITY OF ROCHESTER | $143,850 | Trans-NIH Recovery Act Research Support Stroke remains the third leading cause of death in the US, behind heart disease and cancer. Each year 750,000 Americans suffer a diagnosed stroke and this number will double by 2050, given the advancing average age of the population, barring further devel | National Institutes of Health | 8/17/2009 |
| UNIVERSITY OF ROCHESTER | $138,005 | Trans-NIH Recovery Act Research Support The overall goal of this administrative supplement (to the Career Development Award) is to hire additional personnel to provide critical support in coordinating, collecting, and analyzing human and cat data, as well as to support the purchase of additiona | National Institutes of Health | 9/01/2009 |
| PATHSTONE CORPORATION | $127,516 |
ARRA - Head Start The award received from the Federal government is being used as follows: COLA ARRA 1.84% of $ 917,752 for salary increases and fringe benefits, along with Vehicle Operationals Costs and Vehicle Repair Costs. ARRA Quality Funds have been allocated to the D
This spending item is part of a $3,258,492 allocation.
See details
|
Administration for Children and Families | 7/17/2009 |
| MONROE, COUNTY OF | $125,688 |
Aging Congregate Nutrition Services for States This Senior Nutrition Program is to provide congregate meals for the elderly. The program was built on the Congregate Meals program authorized by Title III-C-1 of the Older American's Act. However, the Administration on Aging has limited the ARRA fundining... Show more
This spending item is part of a $4,148,718 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF ROCHESTER | $120,070 |
Trans-NIH Recovery Act Research Support This proposal for a secondary analysis of data collected in a parent ethnographic study of end-of-life decision making (EOLDM) in intensive care units (ICUs). The current proposal uses qualitative description to focus on the roles of key persons in EOLDM
This spending item is part of a $383,980 allocation.
See details
|
National Institutes of Health | 3/25/2010 |
| UNIVERSITY OF ROCHESTER | $118,631 | Trans-NIH Recovery Act Research Support The supplement covers the cost for replacement of 25-30 year old equipment that is critical to the success of the project. We will purchase a new super-speed centrifuge (about $68K) and a new ultracentrifuge (about $50K). | National Institutes of Health | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $117,294 | Trans-NIH Recovery Act Research Support This administrative supplement requests funds for an SRI EyeLink II eye-tracker to expedite research on-?NIH HD 27206, along with an upgrade to make the eye-tracker portable and software to facilitate experimental design and data analysis and support for | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $114,241 | Trans-NIH Recovery Act Research Support On the parent R21 award, we have established a system of passively transferring protective anti- influenza nucleoprotein monoclonal antibodies into both B lymphocyte-deficient mice as well as normal mice. This is a significant step in allowing the Specifi | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF ROCHESTER | $113,194 | Trans-NIH Recovery Act Research Support The project is to generate transgenic clone of Xenopus with modulated expression of MHC class I, and to generate Xenopus mono-specific antibodies against immunologically important molecules. The overall objective of this renewal application is to safegu | National Institutes of Health | 9/01/2009 |
| The Institute For Matching Person & Technology Inc | $105,000 |
Trans-NIH Recovery Act Research Support One of medicine's greatest challenges today is the efficient, seamless translation of biomedical research discoveries into clinical applications. New methodologies, technologies and integrated information systems offer unprecedented promise for discovery
This spending item is part of a $499,942 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $104,464 | Trans-NIH Recovery Act Research Support The iron-sulfur enzyme nitrogenase converts atmospheric nitrogen into ammonia, but the role of iron in the reaction is not understood. This project studies simple iron compounds in an effort to demonstrate the fundamental reactions taking place in the enz | National Institutes of Health | 8/14/2009 |
| UNITY HOSPITAL OF ROCHESTER, THE | $101,000 | ARRA Health Center Integrated Services Development Initiative[g1] The ARRA IDS funds awarded to the Health Reach, Health Care for the Homeless program were used to purchase and implement an electronic medical record system (EMR); fund an additional 4 hours per week for our Nurse Practitioner and Medidical Assistant/Transp... Show more | Health Resources and Services Administration | 3/23/2009 |
| MONROE, COUNTY OF | $100,000 |
ARRA - Immunization Section 317 grantees have been allocated ARRA funding to purchase priority vaccines. Funding will support operations infrastructure needed to deliver vaccine and account for those vaccinated. Initiatives to be funded with ARRA grant resources are as fol
This spending item is part of a $3,844,764 allocation.
See details
|
Centers for Disease Control and Prevention | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $99,999 | Trans-NIH Recovery Act Research Support Our goal is to acquire an MR-compatible visual display set-up that has an integrated eye-tracker. Our experiments require mapping brain systems that mediate attention and visual short-term memory and how these systems change as a function of the experi | National Institutes of Health | 8/19/2009 |
| UNIVERSITY OF ROCHESTER | $99,948 | Trans-NIH Recovery Act Research Support This project will accelerate studies proposed related to the epigenetic modification of the apob promoter due to changes in methylation status.-? Funds will provide technical support to carry out the proposed experiments.-? The overall goal is to determin | National Institutes of Health | 2/01/2010 |
| UNIVERSITY OF ROCHESTER | $99,875 | Trans-NIH Recovery Act Research Support This award will fund the purchase of equipment to enhance cell imaging by upgrading current microscope equipment and contributing to the purchase of a state-of-the-art multispectral imaging flow cytometer. Our long-term aim is to elucidate the cellular | National Institutes of Health | 1/18/2010 |
| UNIVERSITY OF ROCHESTER | $99,698 | Trans-NIH Recovery Act Research Support An elevation in the [Ca2+]i following secretagogue stimulation plays a fundamental role in underlying digestive enzyme secretion from the exocrine pancreas. The increase in [Ca2+]i is a tightly regulated event and exhibits characteristic temporal and spat | National Institutes of Health | 8/31/2009 |
| UNIVERSITY OF ROCHESTER | $98,503 |
Trans-NIH Recovery Act Research Support Analysis of Differential Resistance Emergence Risk for Differential Treatment Application Schedules This project will develop model-based approaches to therapy switching for HIV which minimize the risk of subsequent treatment failures by simultaneously
This spending item is part of a $396,068 allocation.
See details
|
National Institutes of Health | 6/03/2009 |
| UNIVERSITY OF ROCHESTER | $98,211 | Trans-NIH Recovery Act Research Support This grant is focused on mouse models of slow onset outlet obstruction that results from slow anatomical changes in the mouse lower urinary tract. This supplement provides supplies and personnel support that will enhance our image analysis and computer pr | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF ROCHESTER | $97,705 | Trans-NIH Recovery Act Research Support Metabolic acidosis is a common but potentially life-threatening disorder that occurs when too much acid accumulates in the blood. The kidney is the organ that is primarily concerned with controlling the level of acid in the blood. The cortical collecting | National Institutes of Health | 12/08/2009 |
| HIGHLAND HOSPITAL OF ROCHESTER | $97,458 |
Trans-NIH Recovery Act Research Support The purpose of this administrative supplement is to fund two enhancements to a current K07-funded intervention to promote physical activity in underserved patients. First, we propose a more comprehensive and coordinated physical activity program. Second,
This spending item is part of a $100,064 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $96,163 |
Trans-NIH Recovery Act Research Support We propose to develop a general task prompting and reminding system that runs on an ordinary cell phone for persons with cognitive disabilities. The system will use information from a variety of sensors to determine the user's activity and context, so tha
This spending item is part of a $204,070 allocation.
See details
|
National Institutes of Health | 9/15/2010 |
| UNIVERSITY OF ROCHESTER | $95,323 |
Trans-NIH Recovery Act Research Support Parkinson's disease (PD) is a neurodegenerative disorder characterized by death of substantia nigra (SN) dopamine neurons (DANs), dopamine deficiency within the striatum and a clinical movement disorder. Most PD is sporadic/idiopathic that may arise from
This spending item is part of a $3,907,801 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| PATHSTONE CORPORATION | $94,364 |
ARRA - Head Start The award received from the Federal government is being used as follows: COLA ARRA 1.84% of $ 917,752 for salary increases and fringe benefits, along with Vehicle Operationals Costs and Vehicle Repair Costs. ARRA Quality Funds have been allocated to the D
This spending item is part of a $3,258,492 allocation.
See details
|
Administration for Children and Families | 7/17/2009 |
| UNIVERSITY OF ROCHESTER | $92,803 | Trans-NIH Recovery Act Research Support The purpose of this administrative supplement is to provide funds for the hiring, training, and supply costs of an undergraduate student to expedite the accomplishment of Aim 2 which focuses on defining the consequences of BCDT and targeted biologic antag | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF ROCHESTER | $90,000 | Trans-NIH Recovery Act Research Support There is a very large unmet therapeutic need to treat humans that abuse illegal drugs, especially cocaine. To address this unmet need, this application is focused on the design, synthesis and pharmacological characterization of potential anti-cocaine medi | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $80,004 |
Trans-NIH Recovery Act Research Support This is a collaborative community engagement ARRA supplement request. There are over 80,000 clinical trials conducted each year in the US, and yet, less than 1 percent of the population participates in them. The so-called ?leaky pipe of clinical trial par
This spending item is part of a $594,620 allocation.
See details
|
National Institutes of Health | 8/28/2009 |
| UNIVERSITY OF ROCHESTER | $79,253 |
Trans-NIH Recovery Act Research Support Parkinson?s Disease (PD) as well as other neurodegenerative diseases are associated with oxidative damage. In PD, there is an early reduction in reduced glutathione in the substantia nigra, as well as increases in markers of lipid, protein and DNA oxidati
This spending item is part of a $1,453,349 allocation.
See details
|
National Institutes of Health | 9/16/2009 |
| UNIVERSITY OF ROCHESTER | $78,724 | Trans-NIH Recovery Act Research Support Approximately 40% of the total energy production of E. coli is consumed to synthesize the large number of ribosomal components: 3 RNAs (comprised of more than 400 nucleotides) and greater than 50 proteins. This observation and the direct correlation betwe | National Institutes of Health | 9/09/2009 |
| Rochester Clinical Research, Inc | $77,000 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
| UNIVERSITY OF ROCHESTER | $75,117 | Trans-NIH Recovery Act Research Support The overall purpose is to determine whether or not cystatin C is a useful endogenous marker of GFR in children with chronic kidney disease and whether or not it can replace formal kidney function (glomerular filtration rate) measurements. It will also ser | National Institutes of Health | 9/28/2009 |
| UNIVERSITY OF ROCHESTER | $73,615 | Trans-NIH Recovery Act Research Support Myotonic dystrophy type 1 [DM1] leads to maldevelopment, myotonia, and wasting of skeletal muscle. DM1 is caused by an unstable CTG repeat expansion in the 3' untranslated region of DMPK. Our central hypothesis is that skeletal muscle findings in DM1 resu | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF ROCHESTER | $70,800 | Trans-NIH Recovery Act Research Support A reconditioned-?BNII nephelometer will be purchased and Cystatin C will be measured in sera of subjects in the NIH funded CKiD study. Cystatin C is an endogenous measure of kidney function. The BNII will also be used to measure Cystatin C in subjects of | National Institutes of Health | 12/31/2009 |
| UNIVERSITY OF ROCHESTER | $70,754 | Trans-NIH Recovery Act Research Support Studies of language learning in normal infants and children. Detailed measures of eye tracking to assess language processing and detailed measures of language input to infants by mothers. | National Institutes of Health | 9/25/2009 |
| UNIVERSITY OF ROCHESTER | $68,890 | Trans-NIH Recovery Act Research Support The supplement will allow us to purchase equipment that will allow much more efficient microbiologic evaluation of respiratory and serum specimens collected from volunteers. Two freezers will be purchased to allow storage of patient samples. The equipmen | National Institutes of Health | 9/01/2009 |
| UNIVERSITY OF ROCHESTER | $66,525 |
Trans-NIH Recovery Act Research Support Our parent grant, Patient Navigation Research Program (PNRP) is evaluating the impact of patient navigation on breast cancer (BC), and colorectal cancer (CC) related quality of care and is evaluating the impact of patient navigation on disparities in canc
This spending item is part of a $213,978 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| MONROE, COUNTY OF | $61,838 |
Aging Home-Delivered Nutrition Services for States This Senior Nutrition Program is to provide home delivered meals for the elderly. The program was built on the Home Delivered Meals program authorized by Title III-C-2 of the Older American's Act. However, the Administration on Aging has limited ththe ARR... Show more
This spending item is part of a $2,042,446 allocation.
See details
|
Administration on Aging | 3/18/2009 |
| UNIVERSITY OF ROCHESTER | $60,000 | Trans-NIH Recovery Act Research Support The present Administrative Supplement will help purchase equipment and/or retain personnel to accelerate progress toward understanding the flexibility of neural circuits that control hand and finger movements. Understanding how neurons of the brain flexib | National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $55,700 | Trans-NIH Recovery Act Research Support Funds will be used to purchase a microplate reader capable of UV/visible absorbance measurements, fluorescence, luminescence, FRET (fluorescence resonance energy transfer), BRET (bioluminescence resonance energy transfer), TRF (time resolved fluorescence) | National Institutes of Health | 1/16/2010 |
| UNIVERSITY OF ROCHESTER | $54,000 | Trans-NIH Recovery Act Research Support A one-year supplement is requested to accelerate the tempo of a K23 Award focused on the translation of efficacious interventions to community settings. Since the time of initial funding, two new settings have opened one local, one national in scope that | National Institutes of Health | 7/22/2009 |
| THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | $50,000 | Trans-NIH Recovery Act Research Support Treatment options for GI motility disorders are limited, reflecting the need for new model systems and for identification of new, effective drug targets. The specific objective of this AREA proposal is to establish the zebrafish as a model system to study | National Institutes of Health | 1/26/2010 |
| UNIVERSITY OF ROCHESTER | $49,742 | Trans-NIH Recovery Act Research Support This summer research experience grant is to provide one undergraduate student and one science educator jobs for the summer learning how to conduct and analyze scientific experiments. | National Institutes of Health | 5/28/2009 |
| UNIVERSITY OF ROCHESTER | $49,538 | Trans-NIH Recovery Act Research Support Recently, an autosomal recessive K+ wasting syndrome (SeSAME/EAST syndrome) was reported in several families which linked to the Kir4.1 gene locus (KCNJ10).-?-?-? Six Kir4.1 mutations were reported.-? The patients had seizures, deafness, and ataxia along | National Institutes of Health | 12/21/2009 |
| UNIVERSITY OF ROCHESTER | $46,125 | Trans-NIH Recovery Act Research Support This supplement-?is intended to accelerate the development of an AAV4-BDNF and noggin-based HD treatment strategy, by expanding our assessment of this approach to the non-human primate brain. We intend to assess the efficacy of AAV4-mediated BDNF/Noggin i | National Institutes of Health | 9/24/2009 |
| UNIVERSITY OF ROCHESTER | $41,931 | Trans-NIH Recovery Act Research Support The supplement will provide detailed pharmaceutical data to determine if women who receive an epidural during delivery are at higher risk for premature breastfeeding termination or early supplementation with formula. The parent grant will use these findin | National Institutes of Health | 9/29/2009 |
| UNIVERSITY OF ROCHESTER | $41,500 |
ARRA - Preventing Healthcare-Associated Infections The major goal of this project is to evaluate surveillance, prevention and control strategies for Clostridium difficle infections in acute care hospitals and develop a long term healthcare-associated infections prevention plan.
This spending item is part of a $1,599,048 allocation.
See details
|
Centers for Disease Control and Prevention | 8/31/2009 |
| ROCHESTER INSTITUTE OF TECHNOLOGY | $41,000 |
Trans-NIH Recovery Act Research Support NTHI Immunity in Young Children (Summer supplement): The parent grant seeks to understand the pathogenesis of Nontypable Haemophilus influenzae (NTHi), one of the major etiological agents of acute otitis media (AOM), which has very high morbidity among c
This spending item is part of a $68,800 allocation.
See details
|
National Institutes of Health | 6/30/2009 |
| UNIVERSITY OF ROCHESTER | $40,926 | Trans-NIH Recovery Act Research Support Nasonia is a genus of four insect species that is quickly emerging as a model system, particularly for the genetics of complex traits, development, and microbial-host interactions. It has several features that make it an excellent genetic system. These in | National Institutes of Health | 6/18/2010 |
| UNIVERSITY OF ROCHESTER | $40,347 | Trans-NIH Recovery Act Research Support G proteins 23 subunits play a central role in G-protein coupled receptor (GPCR)- mediated signal transduction. They act as cofactors in the receptor-mediated activation process as well as playing direct roles in signal transfer to downstream targets. Cons | National Institutes of Health | 4/09/2010 |
| VOLUNTEERS OF AMERICA OF WESTERN NEW YORK, INC. | $40,033 |
ARRA - Head Start This award provides for ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act for the Head Start and Early Head Start programs. Head Start/Early Head Start promote t
This spending item is part of a $812,521 allocation.
See details
|
Administration for Children and Families | 7/02/2009 |
| UNIVERSITY OF ROCHESTER | $39,270 | Trans-NIH Recovery Act Research Support The overall objective of the parent proposal is to elucidate the mechanism through which androgen receptor (AR) regulates B lymphopoiesis. The original proposed studies will test the hypothesis that AR up-regulates proliferation and resistance to apoptos | National Institutes of Health | 1/15/2010 |
| UNIVERSITY OF ROCHESTER | $36,711 |
Trans-NIH Recovery Act Research Support The supplementation of vitamin D (vitD) during lactation has been poorly investigated: An expert panel convened by the CDC released a report stating that there are insufficient data to evaluate vitD supplementation requirements during lactation. A CDC stu
This spending item is part of a $72,682 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | $36,132 | Trans-NIH Recovery Act Research Support Melanin-concentrating hormone (MCH) mediates a variety of neurological functions including appetite and energy expenditure. The discovery of MCH receptors in peripheral tissues such as adipose tissue and pancreatic beta cells broadens the potential impact | National Institutes of Health | 9/09/2010 |
| UNIVERSITY OF ROCHESTER | $34,763 |
Trans-NIH Recovery Act Research Support This two-year study will utilize a randomized design with the active interventions running for 18 months. We have 26 active US sites (27 approved sites with one having to drop out due to lack of indirect cost recovery to pay IRB costs). The 26 sites will
This spending item is part of a $1,349,862 allocation.
See details
|
National Institutes of Health | 8/19/2009 |
| UNIVERSITY OF ROCHESTER | $32,474 | Trans-NIH Recovery Act Research Support The current award provides supplementary support to allow us to maintain a currently-employed senior post-doctoral fellow during the last year of the project, which is currently being supported by a no-cost extension based on a limited carryover from the | National Institutes of Health | 9/18/2009 |
| UNIVERSITY OF ROCHESTER | $31,556 | Trans-NIH Recovery Act Research Support The goal of this summer supplement is to provide a summer research experience for a science educator. Effective influenza A vaccines represent a major public health need, both to combat annual virus outbreaks in at-risk populations, and also to protect a | National Institutes of Health | 6/04/2009 |
| UNIVERSITY OF ROCHESTER | $31,521 | Trans-NIH Recovery Act Research Support The summer research experiences for undergraduates will provide numerous avenues to encourage students to pursue research careers in health-related sciences. Opportunities include project and career mentoring, lab meetings, journal clubs, and seminar prog | National Institutes of Health | 6/16/2009 |
| UNIVERSITY OF ROCHESTER | $30,713 |
Trans-NIH Recovery Act Research Support Specific aims of the supplement: Specific Aim 1: To enhance the activities of the CITAD clinical trial by increasing the tempo of participant recruitment by providing $10,000 for two years in direct costs to all study sites. This will result in an earlier
This spending item is part of a $581,127 allocation.
See details
|
National Institutes of Health | 9/04/2009 |
| Virtualscopics, Inc. | $29,975 |
To establish a coordinated process structured to meet previously-identified scientific needs for quantitative imaging biomarkers. The long-term objective is to establish processes and profiles that will lead to acceptance by the imaging community, clinica
This spending item is part of a $2,412,566 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
| UNIVERSITY OF ROCHESTER | $29,568 | Trans-NIH Recovery Act Research Support The overall purpose of the award is to employee two undergraduate summer students to give them experience within a laboratory environment to help in the educational experience and to collect data relevant to the Aims of the parent award. | National Institutes of Health | 7/19/2009 |
| THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | $29,278 | Trans-NIH Recovery Act Research Support Treatment options for GI motility disorders are limited, reflecting the need for new model systems and for identification of new, effective drug targets. The specific objective of this AREA proposal is to establish the zebrafish as a model system to study | National Institutes of Health | 6/18/2010 |
| ROCHESTER GENERAL HOSPITAL | $27,800 |
Trans-NIH Recovery Act Research Support NTHI Immunity in Young Children (Summer supplement): The parent grant seeks to understand the pathogenesis of Nontypable Haemophilus influenzae (NTHi), one of the major etiological agents of acute otitis media (AOM), which has very high morbidity among c
This spending item is part of a $68,800 allocation.
See details
|
National Institutes of Health | 6/30/2009 |
| UNIVERSITY OF ROCHESTER | $25,139 |
Trans-NIH Recovery Act Research Support In August 2011, the second manuscript for this project was accepted for publication in the Journal of Autoimmunity. The article entitled G?Antigenic Challenge in the Etiology of Autoimmune Disease in WomenG? will be published in a special issue regarding
This spending item is part of a $438,412 allocation.
See details
|
National Institutes of Health | 5/18/2009 |
| CARESTREAM HEALTH INC | $24,420 | Provide imaging technology to convert films to digital images for soft copy display and interpretation. | Program Support Center | 9/28/2010 |
| UNIVERSITY OF ROCHESTER | $21,343 |
Trans-NIH Recovery Act Research Support Intravenous recombinant tissue plasminogen activator (IV rt-PA) is an effective therapy for acute ischemic stroke but has substantial limitations when used alone to open occluded major extracranial and intracranial arteries. The EMS and IMS I Pilot Studie
This spending item is part of a $335,100 allocation.
See details
|
National Institutes of Health | 9/07/2009 |
| UNIVERSITY OF ROCHESTER | $17,310 |
ARRA - Immunization Although overall childhood immunization rates are high some parents defer or decline vaccinations for their children because of their concerns about vaccine safety. Research has shown that physician recommendations greatly influence parents in their vacc
This spending item is part of a $320,554 allocation.
See details
|
Centers for Disease Control and Prevention | 9/21/2009 |
| ROCHESTER INSTITUTE OF TECHNOLOGY (INC) | $16,059 |
Trans-NIH Recovery Act Research Support NTHi Immunity in Young Children (Accelerating the Science supplement): Within the scope of the parent study of acute otitis media (AOM), this supplemental project seeks support to accelerate the tempo of scientific research, increase diversity recruitmen
This spending item is part of a $309,776 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| CARESTREAM HEALTH INC | $15,756 | Tabletop laser imager for the San Zavier Radiology Department | Indian Health Service | 7/19/2009 |
| IBERO-AMERICAN ACTION LEAGUE, INC. | $14,335 |
ARRA - Head Start This award provides for ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act for the Head Start and Early Head Start programs. Head Start/Early Head Start promote t
This spending item is part of a $812,521 allocation.
See details
|
Administration for Children and Families | 7/02/2009 |
| UNIVERSITY OF ROCHESTER | $12,101 | Trans-NIH Recovery Act Research Support The purpose of this project is to provide an underdraduate student training opportunity in field of heme metablism and cell signaling. The heme moiety of denatured hemoproteins (heme-proteins) is degraded by HO-1 & HO-2, to CO and biliverdin (BV), an HO | National Institutes of Health | 7/11/2009 |
| UNIVERSITY OF ROCHESTER | $10,460 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| ROCHESTER INSTITUTE OF TECHNOLOGY | $9,720 | Trans-NIH Recovery Act Research Support This administrative supplement (part of NIH's stimulus funding) is to provide summer research experiences for students, and is a supplement to the PI's current NIH NIA K01 grant. Four undergraduate students (two each year) will participate on the project | National Institutes of Health | 6/22/2009 |
| UNIVERSITY OF ROCHESTER | $9,657 | Trans-NIH Recovery Act Research Support The supplement will provide detailed pharmaceutical data to determine if women who receive an epidural during delivery are at higher risk for premature breastfeeding termination or early supplementation with formula. The parent grant will use these findin | National Institutes of Health | 6/24/2009 |
| UNIVERSITY OF ROCHESTER | $8,932 | Trans-NIH Recovery Act Research Support This award is to support Summer Research Experiences for Students and Science Educators. It will focus on further characterizing the expression pattern of IFN- and TNF, by RT-PCR and qPCR. In parallel, we will also generate constructs to express IFN- and | National Institutes of Health | 7/14/2009 |
| UNIVERSITY OF ROCHESTER | $8,932 | Trans-NIH Recovery Act Research Support Heat shock proteins and non-classical MHC class Ib are postulated to be important modulators of anti-tumor immune responses.The goal of the project is to learn, using the frog Xenopus as a non-mammalian comparative model, how these proteins can protect us | National Institutes of Health | 6/01/2009 |
| UNIVERSITY OF ROCHESTER | $6,608 | Trans-NIH Recovery Act Research Support The supplement is to fund an undergraduate student to spend 8 weeks in my laboratory this summer investigating the terminal differentiation of primitive erythroid cells. The summer research experience is designed to encourage undergraduate students to ser | National Institutes of Health | 7/16/2009 |
| YMCA of Greater Rochester | $4,458 |
ARRA - Head Start This award provides for ARRA Cost of Living Adjustment (COLA) and Quality Improvement Funding consistent with the provisions of Section 640(a)(5) of the Head Start Act for the Head Start and Early Head Start programs. Head Start/Early Head Start promote t
This spending item is part of a $812,521 allocation.
See details
|
Administration for Children and Families | 7/02/2009 |
| UNIVERSITY OF ROCHESTER | $3,120 | Trans-NIH Recovery Act Research Support The Neuronal Ceroid Lipofuscinoses (NCL) is probably the most frequent group of progressive inherited neurodegenerative diseases with childhood onset. They can start at all ages and progression is characterized by one or more of the following symptoms: vi | National Institutes of Health | 5/15/2009 |
| UNIVERSITY OF ROCHESTER | $2,606 |
Trans-NIH Recovery Act Research Support The purpose of this administrative supplement is to fund two enhancements to a current K07-funded intervention to promote physical activity in underserved patients. First, we propose a more comprehensive and coordinated physical activity program. Second,
This spending item is part of a $100,064 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
| UNIVERSITY OF ROCHESTER | $2,196 |
Trans-NIH Recovery Act Research Support The funds will be used to develop, open and analyze three H1N1 studies in HIV-infected populations. The first study will determine the safety and immunogenicity of an H1N1 vaccine in HIV-infected pregnant women. The second study will determine safety an
This spending item is part of a $1,701,287 allocation.
See details
|
National Institutes of Health | 11/25/2009 |
| UNIVERSITY OF ROCHESTER | $0 |
Trans-NIH Recovery Act Research Support The supplement will provide funding for a post doctoral scientist to work on the project at the sub-award institution. The pace of research will be accelerated by this hire. A key event in the secretagogue stimulation of both the fluid and protein compo
This spending item is part of a $186,806 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
| WESTSIDE HEALTH SERVICES INC | $0 |
ARRA Health Center Integrated Services Development Initiative[g1] IDS Grant is for recruitment and retention of employees. The need at the facility is to expand and retain the clinical team in order to meet the need of the patients at that facility(Westside) and Anthony Jordan is seeing a rise in dedemand for services fr... Show more
This spending item is part of a $285,815 allocation.
See details
|
Health Resources and Services Administration | 3/27/2009 |
| WESTSIDE HEALTH SERVICES INC | $0 |
ARRA Health Center Integrated Services Development Initiative[g1] IDS Grant is for recruitment and retention of employees
This spending item is part of a $285,815 allocation.
See details
|
Health Resources and Services Administration | 6/29/2009 |